Health-related quality of life outcomes at 1 and 5 years after a residential retreat promoting lifestyle modification for people with multiple sclerosis

Neurological Sciences

Volumn 34, Issue 2, 2013, Pages 187-195

  Hadgkiss, Emily J ^a   Jelinek, George A ^a,b,c   Weiland, Tracey J ^a,b   Rumbold, Greg ^c   Mackinlay, Claire A ^a   Gutbrod, Siegfried ^c   Gawler, Ian ^c  

^a ST VINCENT S HOSPITAL   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c The Gawler Foundation   (Australia)

Author keywords

Lifestyle; MSQOL 54; Multiple sclerosis; Quality of life; Well being

Indexed keywords

COLECALCIFEROL; OMEGA 3 FATTY ACID; STEROID;

ADULT; ARTICLE; AUSTRALIA; COST EFFECTIVENESS ANALYSIS; EVALUATION AND FOLLOW UP; EXERCISE; FEMALE; FRIEDMAN TEST; HEALTH PROGRAM; HEALTH PROMOTION; HEALTH SURVEY; HUMAN; LIFESTYLE MODIFICATION; MAJOR CLINICAL STUDY; MALE; MEDITATION; METHODOLOGY; MSQOL 54; MULTIPLE SCLEROSIS; OUTCOME ASSESSMENT; PATIENT CARE; QUALITY OF LIFE; RESIDENTIAL CARE; RESIDENTIAL RETREAT; SUNLIGHT; TIME; TIME POINT; WELLBEING; WILCOXON SIGNED RANKS TEST;

ADULT; AUSTRALIA; FEMALE; FOLLOW-UP STUDIES; HEALTH STATUS; HUMANS; LIFE STYLE; MALE; MENTAL HEALTH; MULTIPLE SCLEROSIS; PERSONAL SATISFACTION; QUALITY OF LIFE; QUESTIONNAIRES; TREATMENT OUTCOME;

EID: 84877250521     PISSN: 15901874     EISSN: 15903478     Source Type: Journal    
DOI: 10.1007/s10072-012-0982-4     Document Type: Article

References (48)

1. Murray TJ (2006) Diagnosis and treatment of multiple sclerosis. BMJ 332:525-527
2. Koutsouraki E, Costa V, Baloyannis S (2010) Epidemiology of multiple sclerosis in Europe: a review. Int Rev Psychiatry 22:2-13
3. Marrie RA (2004) Environmental risk factors in multiple sclerosis aetiology. Lancet Neurol 3:709-718
4. Ziemssen T (2009) Multiple sclerosis beyond EDSS: depression and fatigue. J Neurol Sci 277(Suppl 1):S37-S41
5. Simmons RD (2010) Life issues in multiple sclerosis. Nat Rev Neurol 6:603-610
6. Clegg A, Bryant J (2001) Immunomodulatory drugs for multiple sclerosis: a systematic review of clinical and cost effectiveness. Expert Opinion on Pharmacother 2:623-639
7. Chaudhuri A, Behan PO (2005) Treatment of multiple sclerosis: beyond the NICE guidelines. QJM 98:373-378
8. Bryant J, Clegg A, Milne R (2001) Systematic review of immunomodulatory drugs for the treatment of people with multiple sclerosis: Is there good quality evidence on effectiveness and cost? J Neurol Neurosurg Psychiatry 70:574-579
9. Tremlett H, Zhao Y, Ricckmann P, Hutchinson M (2010) New perspectives in the natural history of multiple sclerosis. Neurol 74:2004-2015
10. D'Hooghe MB, Nagels G, Bissay V, De Keyser J (2010) Modifiable factors influencing relapses and disability in multiple sclerosis. Mult Scler 16:773-785
11. Jelinek GA, Hassed CS (2009) Managing multiple sclerosis in primary care: are we forgetting something? Qual Prim Care 17:55-61
12. Leong EM, Semple SJ, Angley M, Siebert W, Petkov J, McKinnon RA (2009) Complementary and alternative medicines and dietary interventions in multiple sclerosis: what is being used in South Australia and why? Complem Ther Med 17:216-223
13. Stuifbergen AK, Morris M, Jung JH, Pierini D, Morgan S (2010) Benefits of wellness interventions for persons with chronic and disabling conditions: a review of the evidence. Disabil Health J 3:133-145
14. Watt D, Verma S, Flynn L (1998) Wellness programs: a review of the evidence. CMAJ 158:224-230
15. Li MP, Jelinek GA, Weiland TJ, Mackinlay CA, Dye S, Gawler I (2010) Effect of a residential retreat promoting lifestyle modifications on health-related quality of life in people with multiple sclerosis. Qual Prim Care 18:379-389
16. Jelinek GA (2010) Overcoming multiple sclerosis mana retreat. http://bit.ly/oOVOUl. Accessed October 13 2011
17. Jelinek GA (2005) Taking control of multiple sclerosis: natural and medical therapies to prevent its progression. Fleetbooks, Lancaster
18. Jelinek GA (2010) Overcoming multiple sclerosis: an evidence-based guide to recovery. Allen and Unwin, Sydney
19. Jelinek GA (2011) The Overcoming Multiple Sclerosis Recovery Program. http://www.overcomingmultiplesclerosis.org/. Accessed September 15 2011
20. Vickrey BG, Hays RD, Harooni R, Myers LW, Ellison GW (1995) A health-related quality of life measure for multiple sclerosis. Qual Life Res 4:187-206
21. Idiman E, Uzunel F, Ozakbas S, Yozbatiran N, Oguz M, Callioglu B, Gokce N, Bahar Z (2006) Cross-cultural adaptation and validation of multiple sclerosis quality of life questionnaire (MSQOL-54) in a Turkish multiple sclerosis sample. J Neurol Sci 240:77-80
22. Heiskanen S, Merilainen P, Pietila A-M (2007) Health-related quality of life-testing the reliability of the MSQOL-54 instrument among MS patients. Scandinav J Caring Sci 21:199-206
23. Pekmezovic T, Kisic Tepavcevic D, Kostic J, Drulovic J (2007) Validation and cross-cultural adaptation of the disease-specific questionnaire MSQOL-54 in Serbian multiple sclerosis patients sample. Qual Life Res 16:1383-1387
24. Solari A, Filippini G, Mendozzi L, Ghezzi A, Cifani S, Barbieri E, Baldini S, Salmaggi A, Mantia LL, Farinotti M, Caputo D, Mosconi P (1999) Validation of Italian multiple sclerosis quality of life 54 questionnaire. J Neurol Neurosurg Psychiatry 67:158-162
25. Miller D, Rudick RA, Hutchinson M (2010) Patient-centered outcomes: translating clinical efficacy into benefits on health-related quality of life. Neurol 74(Suppl 3):S24-S35
26. Nortvedt MW, Riise T (2003) The use of quality of life measures in multiple sclerosis research. Mult Scler 9:63-72
27. Opara JA, Jaracz K, Brola W (2010) Quality of life in multiple sclerosis. J Med Life 3:352-358
28. Gold SM, Schulz H, Monch A, Schulz KH, Heesen C (2003) Cognitive impairment in multiple sclerosis does not affect reliability and validity of self-report health measures. Mult Scler 9:404-410
29. Ingram G, Colley E, Ben-Shlomo Y, Cossburn M, Hirst C, Pickersgill T, Robertson N (2010) Validity of patient-derived disability and clinical data in multiple sclerosis. Mult Scler 16:472-479
30. Jose Sa M (2008) Psychological aspects of multiple sclerosis. Clin Neurol Neurosurg 110:868-877
31. Dennison L, Moss-Morris R, Chalder T (2009) A review of psychological correlates of adjustment in patients with multiple sclerosis. Clin Psychol Rev 29:141-153
32. White CP, White MB, Russell CS (2008) Invisible and visible symptoms of multiple sclerosis: which are more predictive of health distress? J Neurosci Nurs 40:85-95
33. Mohr DC, Hart SL, Julian L, Cox D, Pelletier D (2004) Association between stressful life events and exacerbation in multiple sclerosis: a meta-analysis. BMJ 328:731
34. Mohr DC, Goodkin DE, Nelson S, Cox D, Weiner M (2002) Moderating effects of coping on the relationship between stress and the development of new brain lesions in multiple sclerosis. Psychosom Med 64:803-809
35. Flynn S (2002) Multiple sclerosis: the Treetops model of residential care. Br J Nurs 11(9):635-642
36. Rothwell PM, McDowell Z, Wong CK, Dorman PJ (1997) Doctors and patients don't agree: cross sectional study of patients' and doctors' perceptions and assessments of disability in multiple sclerosis. BMJ 314:1580-1583
37. Pelzang R (2010) Time to learn: understanding patient-centred care. Br J Nurs 19:912-917
38. Wallin MT (2010) Integrated multiple sclerosis care: new approaches and paradigm shifts. J Rehab Res Dev 47:ix-xiv
39. Mosen DM, Schmittdiel J, Hibbard J, Sobel D, Remmers C, Bellows J (2007) Is patient activation associated with outcomes of care for adults with chronic conditions? J Ambul Care Manage 30:21-29
40. Kessler TM, Fowler CJ, Panicker JN (2009) Sexual dysfunction in multiple sclerosis. Expert Rev Neurother 9:341-350
41. Tepavcevic DK, Kostic J, Basuroski ID, Stojsavljevic N, Pekmezovic T, Drulovic J (2008) The impact of sexual dysfunction on the quality of life measured by MSQoL-54 in patients with multiple sclerosis. Mult Scler 14:1131-1136
42. Fletcher SG, Castro-Borrero W, Remington G, Treadaway K, Lemack GE, Frohman EM (2009) Sexual dysfunction in patients with multiple sclerosis: a multidisciplinary approach to evaluation and management. Nat Clin Pract Urol 6:96-107
43. Miller DM, Rudick RA, Baier M, Cutter G, Doughtery DS, Weinstock-Guttman B, Mass MK, Fisher E, Simonian N (2003) Factors that predict health-related quality of life in patients with relapsing-remitting multiple sclerosis. Mult Scler 9:1-5
44. Hopman WM, Coo H, Pavlov A, Day AG, Edgar CM, McBride EV, Brunet DG (2009) Multiple sclerosis: change in health-related quality of life over two years. Can J Neurol Sci 36:554-561
45. Solari A, Ferrari G, Radice D (2006) A longitudinal survey of self-assessed health trends in a community cohort of people with multiple sclerosis and their significant others. J Neurol Sci 243:13-20
46. Wynia K, Wijlen AV, Middel B, Reijneveld S, Meilof J (2011) Change in disability profile and quality of life in multiple sclerosis patients: a five-year longitudinal study using the Multiple Sclerosis Impact Profile (MSIP). Mult Scler. doi: 10.1177/1352458511423935
47. Stuifbergen AK, Becker H, Blozis S, Timmerman G, Kullberg V (2003) A randomized clinical trial of a wellness intervention for women with multiple sclerosis. Arch Phys Med Rehabil 84:467-476
48. Glad S, Nyland H, Myhr KM (2006) Benign multiple sclerosis. Acta Neurol Scand Suppl 183:55-57